Pfizer raises earnings outlook as COVID vaccine sales drive Q3 beat
Pfizer (PFE) exceeded Street forecasts with its Q3 2025 results on Tuesday, thanks mainly to sales from its COVID vaccine developed with BioNTech (BNTX), and the company raised its full-year earnings outlook while reaffirming the revenue guidance. However,...
Seeking Alpha